InsiderClue
Insiders · Profile

Lettmann Jason

CHIEF EXECUTIVE OFFICER at ALX ONCOLOGY. Filing since 21 Jul 2020. CIK 0001688269

Company
Date
Role
Action
Shares
Amount
Of holding
ALXO ALX ONCOLOGY HOLDINGS INC
17 Aug 2026
CHIEF EXECUTIVE OFFICER
Sold at will
2,230
$4.30K
0.8%
ALXO ALX ONCOLOGY HOLDINGS INC
19 Mar 2026
CHIEF EXECUTIVE OFFICER
Sold at will
12,311
$26.71K
4.0%
ALXO ALX ONCOLOGY HOLDINGS INC
17 Sep 2025
CHIEF EXECUTIVE OFFICER
Bought
71,163
$76.89K
30.4%
ALXO ALX ONCOLOGY HOLDINGS INC
16 Sep 2025
CHIEF EXECUTIVE OFFICER
Bought
21,070
$22.46K
9.9%
ALXO ALX ONCOLOGY HOLDINGS INC
15 Aug 2025
CHIEF EXECUTIVE OFFICER
Sold at will
2,382
$1.53K
1.1%
ALXO ALX ONCOLOGY HOLDINGS INC
19 Feb 2025
CHIEF EXECUTIVE OFFICER
Sold at will
2,159
$2.48K
1.3%
ALXO ALX ONCOLOGY HOLDINGS INC
14 Mar 2024
CHIEF EXECUTIVE OFFICER
Bought
4,400
$49.77K
2.6%
ALXO ALX ONCOLOGY HOLDINGS INC
13 Dec 2021
Director
Sold, plan not stated
325,377
$8.90M
53.2%
ALXO ALX ONCOLOGY HOLDINGS INC
10 Dec 2021
Director
Sold, plan not stated
26,274
$822.72K
8.3%
ALXO ALX ONCOLOGY HOLDINGS INC
9 Dec 2021
Director
Sold, plan not stated
76,905
$2.46M
20.7%
ALXO ALX ONCOLOGY HOLDINGS INC
8 Dec 2021
Director
Sold, plan not stated
42,458
$1.41M
12.3%
ALXO ALX ONCOLOGY HOLDINGS INC
21 Jul 2020
Director
Bought
400,000
$7.60M
opened
12 decisions on file.